Byrne Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-50
| Closed | -$444 | – | 580 |
|
|
2025
Q1 | $444 | Hold |
50
| – | – | ﹤0.01% | 545 |
|
|
2024
Q4 | $686 | Sell |
50
-200
| -80% | -$2.74K | ﹤0.01% | 524 |
|
|
2024
Q3 | $6.85K | Hold |
250
| – | – | ﹤0.01% | 432 |
|
|
2024
Q2 | $6.08K | Hold |
250
| – | – | ﹤0.01% | 429 |
|
|
2024
Q1 | $5.33K | Hold |
250
| – | – | ﹤0.01% | 429 |
|
|
2023
Q4 | $4.95K | Sell |
250
-250
| -50% | -$4.95K | ﹤0.01% | 416 |
|
|
2023
Q3 | $8K | Hold |
500
| – | – | 0.01% | 362 |
|
|
2023
Q2 | $12K | Buy |
+500
| New | +$12K | 0.01% | 382 |
|